American Healthcare REIT, Inc. AHR
Set alert
53.52 USD +0.58 +1.10%
At close · Oct 30
53.52 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
52.98 Day range 54.20
45.30 52-week range 57.72
- YTD
- +13.73%
- 1 year
- +18.15%
- Open
- 53.47
- Prev close
- 52.94
- Mkt cap
- 11.67B
- Vol
- 2.91M
- Avg vol
- 3.11M
- EPS
- 0.67
- P/E
- 79.88
- Div yield
- 1.89%
More statistics
- Low
- 52.98
- High
- 54.20
- Forward P/E
- 54.07
- Beta
- 0.80
- Short ratio
- 9.67
- Inst. own
- 100.04%
- Dividend
- 1.00
- Ex-div date
- Sep 29, 2026
- Earnings
- Nov 5, 2026
- 50-d avg
- 53.21
- 200-d avg
- 51.44
- 1y target
- 63.69
2Y chart
Events in this range
- Dec 31, 2024Dividend: 0.25
- Mar 31, 2025Dividend: 0.25
- Jun 30, 2025Dividend: 0.25
- Aug 7, 2025Earnings: 0.06; estimate 0.4; surprise -85%
- Sep 30, 2025Dividend: 0.25
- Nov 6, 2025Earnings: 0.33; estimate 0.42; surprise -21.43%
- Dec 31, 2025Dividend: 0.25
- Feb 26, 2026Earnings: 0.06; estimate 0.1549; surprise -61.27%
- Mar 31, 2026Dividend: 0.25
- May 7, 2026Earnings: 0.13; estimate 0.1609; surprise -19.2%
- Jun 30, 2026Dividend: 0.25
- Aug 6, 2026Earnings: 0.16; estimate 0.1372; surprise 16.62%
- Aug 19, 2026Rating: Keybanc · Overweight → Overweight
- Aug 31, 2026Rating: Barclays · Overweight → Overweight
- Sep 2, 2026Rating: Scotiabank · Sector Outperform → Sector Outperform
- Sep 30, 2026Dividend: 0.25
- Oct 13, 2026Rating: Raymond James · — → Strong Buy
- Oct 13, 2026Rating: Barclays · Overweight → Overweight
- Oct 13, 2026Rating: UBS · Buy → Buy
Signals (92)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 2026 | 2 days ago |
| SMA: Bullish | Oct 28, 2026 | 4 days ago |
| SMA: Bearish | Oct 27, 2026 | 5 days ago |
| SMA: Bearish | Oct 27, 2026 | 5 days ago |
| SMA: Bullish | Oct 26, 2026 | 6 days ago |
| SMA: Bearish | Oct 21, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bullish | Oct 12, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 12, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 5, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 4, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 3, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 1, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 31, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 24, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 30, 2026 | 3 months ago |
| RSI: Overbought | Jul 21, 2026 | 3 months ago |
| RSI: Overbought | Jul 16, 2026 | 3 months ago |
| RSI: Overbought | Jul 7, 2026 | 3 months ago |
| RSI: Overbought | Jul 1, 2026 | 4 months ago |
| SMA: Bullish | Jun 24, 2026 | 4 months ago |
| SMA: Bullish | Jun 23, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 22, 2026 | 4 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bearish | May 28, 2026 | 5 months ago |
| MACD: Sell Signal | May 21, 2026 | 5 months ago |
| MACD: Buy Signal | May 20, 2026 | 5 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| MACD: Sell Signal | May 18, 2026 | 5 months ago |
| SMA: Bearish | May 15, 2026 | 5 months ago |
| SMA: Bullish | May 8, 2026 | 5 months ago |
| SMA: Bearish | May 1, 2026 | 6 months ago |
| SMA: Bullish | Apr 30, 2026 | 6 months ago |
| SMA: Bearish | Apr 24, 2026 | 6 months ago |
| SMA: Bullish | Apr 23, 2026 | 6 months ago |
| SMA: Bearish | Apr 17, 2026 | 6 months ago |
| SMA: Bullish | Apr 16, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 9, 2026 | 6 months ago |
| RSI: Oversold | Mar 27, 2026 | 7 months ago |
| SMA: Bearish | Mar 20, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 4, 2026 | 8 months ago |
| RSI: Overbought | Feb 13, 2026 | 8 months ago |
| SMA: Bullish | Feb 5, 2026 | 8 months ago |
| SMA: Bearish | Feb 4, 2026 | 9 months ago |
| SMA: Bullish | Feb 3, 2026 | 9 months ago |
| MACD: Buy Signal | Feb 2, 2026 | 9 months ago |
| SMA: Bearish | Jan 22, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 22, 2026 | 9 months ago |
| SMA: Bullish | Jan 21, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 14, 2026 | 9 months ago |
| SMA: Bearish | Dec 31, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 3, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 28, 2025 | 11 months ago |
| RSI: Overbought | Nov 28, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 21, 2025 | 11 months ago |
| RSI: Overbought | Nov 18, 2025 | 11 months ago |
| RSI: Overbought | Nov 3, 2025 | 12 months ago |
| SMA: Bullish | Oct 15, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 15, 2025 | 1 year ago |
| SMA: Bearish | Oct 3, 2025 | 1 year ago |
| RSI: Overbought | Sep 4, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 2, 2025 | 1 year ago |
| RSI: Overbought | Aug 18, 2025 | 1 year ago |
| RSI: Overbought | Aug 8, 2025 | 1 year ago |
| RSI: Overbought | Aug 4, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 31, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 25, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 16, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 25, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 24, 2025 | 1 year ago |
| MACD: Sell Signal | May 22, 2025 | 1 year ago |
| RSI: Overbought | May 15, 2025 | 1 year ago |
| RSI: Overbought | May 9, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 15, 2025 | 1 year ago |
| SMA: Bullish | Apr 11, 2025 | 1 year ago |
| SMA: Bearish | Apr 4, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 4, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 19, 2025 | 1 year ago |
| SMA: Bullish | Mar 11, 2025 | 1 year ago |
| SMA: Bearish | Mar 10, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 10, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 26, 2025 | 1 year ago |
| SMA: Bullish | Feb 25, 2025 | 1 year ago |
| SMA: Bearish | Feb 14, 2025 | 1 year ago |
| SMA: Bullish | Feb 13, 2025 | 1 year ago |
| SMA: Bearish | Feb 11, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 11, 2025 | 1 year ago |
| SMA: Bullish | Feb 3, 2025 | 1 year ago |
| SMA: Bearish | Jan 31, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 23, 2025 | 1 year ago |
| SMA: Bullish | Jan 15, 2025 | 1 year ago |
Key statistics
- Market cap
- 11.67B
- Enterprise value
- 13.00B
- Trailing P/E
- 79.90
- Forward P/E
- 54.07
- PEG ratio
- 0.00
- Price / sales
- 4.66
- Price / book
- 2.82
- EPS (TTM)
- 0.67
- Beta
- 0.80
- Dividend yield
- 1.89%
- Payout ratio
- 149.25%
- Profit margin
- 4.83%
- Revenue (TTM)
- 2.50B
- Revenue growth
- 24.70%
- Free cash flow
- 396.68M
- Total cash
- 157.85M
- Total debt
- 1.57B
- Return on equity
- 3.95%
- Shares outstanding
- 218.00M
- Short % of float
- 17.28%
- 50-day average
- 53.21
- 200-day average
- 51.44
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 63.69 +19.0% upside
Now 53.52
- Target (low)
- 55.00
- Target (mean)
- 63.69
- Target (high)
- 74.00
Ratings (0m) 16 16 buy · 0 hold · 0 sell
- Strong buy6
- Buy10
- Hold0
- Sell0
- Strong sell0
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate 0.16.
Financials — quick view
AHR Revenue — quarterly 674.25M
AHR Net income — quarterly 30.61M
AHR EPS — quarterly 0.16
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Sep 30, 2026 | 0.1539 | — | — | — |
| Aug 6, 2026 | Jun 30, 2026 | 0.1372 | 0.16 | +0.02 | +16.62% |
| May 7, 2026 | Mar 31, 2026 | 0.1609 | 0.13 | -0.03 | -19.20% |
| Feb 26, 2026 | Dec 31, 2025 | 0.1549 | 0.06 | -0.09 | -61.27% |
| Nov 6, 2025 | Sep 30, 2025 | 0.42 | 0.33 | -0.09 | -21.43% |
| Aug 7, 2025 | Jun 30, 2025 | 0.40 | 0.06 | -0.34 | -85.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 13, 2026 | UBS | main | Buy | Buy |
| Oct 13, 2026 | Barclays | main | Overweight | Overweight |
| Oct 13, 2026 | Raymond James | init | — | Strong Buy |
| Sep 2, 2026 | Scotiabank | main | Sector Outperform | Sector Outperform |
| Aug 31, 2026 | Barclays | main | Overweight | Overweight |
| Aug 19, 2026 | Keybanc | main | Overweight | Overweight |
About American Healthcare REIT, Inc.
American Healthcare REIT, Inc., a Maryland-based self-managed REIT, owns and operates a diversified portfolio of clinical healthcare real estate across the U.S., U.K., and the Isle of Man. Its focus includes senior housing, skilled nursing facilities (SNFs), outpatient medical (OM) buildings, and other healthcare-related properties. The company utilizes a fully integrated management platform and operates senior housing under the RIDEA structure. In addition to owning and operating properties, it has originated and acquired secured loans and may pursue other real estate-related investments opportunistically. The REIT seeks income-generating assets and selectively develops healthcare properties. It has elected to be taxed as a REIT under the U.S. Internal Revenue Code and intends to maintain compliance with REIT requirements. American Healthcare REIT, Inc. is based in Irvine, United States.
- Sector
- Real Estate
- Industry
- REIT - Healthcare Facilities
- Country
- United States
- Website
- americanhealthcarereit.com
News
- Is American Healthcare REIT, Inc. (AHR) Stock Outpacing Its Finance Peers This Year?
- UBS Maintains Buy on American Healthcare REIT, Lowers Price Target to $62
- Barclays Maintains Overweight on American Healthcare REIT, Lowers Price Target to $60
- This Electra Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
- Raymond James Initiates Coverage On American Healthcare REIT with Strong Buy Rating, Announces Price Target of $62
- Here's Why American Healthcare REIT (AHR) is Poised for a Turnaround After Losing 7.8% in 4 Weeks
- Are Finance Stocks Lagging American Healthcare REIT, Inc. (AHR) This Year?
- American Healthcare REIT Announces Dates for Third Quarter 2026 Earnings Release and Conference Call
- American Healthcare REIT, Inc. (NYSE:AHR) Shareholders to Get $0.25 Quarterly Dividend
- 3 Equity REIT Stocks Worth Betting on Despite Industry Headwinds
Your note
Sign in to keep a note on AHR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| FLORNES BRIAN J | Director | Stock Award(Grant) | Jun 23, 2026 | 33,020 |
| FOSTER MARK E. | Officer | Sale | Sep 24, 2026 | 50,117 |
| HANSON JEFFREY T. | Director | Sale | Dec 22, 2025 | 0 |
| HURLEY DIANNE | Director | Stock Award(Grant) | Jun 23, 2026 | 34,037 |
| OH STEFAN K.L. | Chief Investment Officer | Conversion of Exercise of derivative security | Apr 5, 2026 | 96,994 |
| PEAY BRIAN SCOTT | Chief Financial Officer | Sale | Jun 25, 2026 | 153,507 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 11.86% | 25,845,948 | 1.38B | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 7.79% | 16,975,438 | 908.70M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.22% | 9,201,599 | 492.56M | Jun 29, 2026 |
| State Street Corporation | 4.15% | 9,046,025 | 484.23M | Jun 29, 2026 |
| Principal Financial Group, Inc. | 4.09% | 8,917,875 | 477.37M | Jun 29, 2026 |
| Wellington Management Group, LLP | 3.97% | 8,658,850 | 463.51M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.56% | 7,765,186 | 415.67M | Sep 29, 2026 |
| VANGUARD SPECIALIZED FUNDS-Vanguard Real Estate Index Fund | 3.35% | 7,298,750 | 390.70M | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.04% | 6,621,174 | 354.43M | Jun 29, 2026 |
| SmallCap World Fund Inc | 2.56% | 5,572,465 | 298.29M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.20% | 4,786,618 | 256.23M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.27% | 2,759,005 | 147.69M | Jun 29, 2026 |